This inventor holds 14 USPTO granted patents and 19 published patent applications, primarily in Stem Cell Research. Top assignee: Frequency Therapeutics, Inc.. Active years: 2018-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2023
Areas of Expertise:
Title: The Innovative Contributions of Will Mclean
Introduction
Will Mclean is a prominent inventor based in North Haven, CT (US), known for his significant contributions to the field of hearing loss treatment. With a total of 14 patents to his name, Mclean has made remarkable strides in developing innovative solutions for auditory health.
Latest Patents
Among his latest patents, Mclean has developed compositions and methods for generating hair cells by downregulating FOXO. This invention provides compositions and methods comprising a FOXO inhibitor aimed at increasing the proliferation of Lgr5+ cochlear cells, along with related methods for treating hearing loss. Another notable patent involves solubilized compositions for controlled proliferation of stem cells, specifically generating inner ear hair cells using a GSK3 inhibitor. This invention focuses on methods of inducing the self-renewal of stem/progenitor supporting cells, allowing these cells to proliferate while retaining the capacity to differentiate into hair cells.
Career Highlights
Mclean's career is marked by his role at Frequency Therapeutics, Inc., where he continues to push the boundaries of auditory research and innovation. His work has garnered attention for its potential to revolutionize treatments for hearing loss.
Collaborations
Mclean collaborates with talented individuals such as Christopher Loose and Megan Harrison, contributing to a dynamic team focused on advancing auditory health solutions.
Conclusion
Will Mclean's innovative work and numerous patents highlight his dedication to improving hearing health through scientific advancements. His contributions are paving the way for future breakthroughs in the treatment of hearing loss.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
